Olanzapine-induced hypertriglyceridemia in cancer care: A silent metabolic risk
Olanzapine (Zyprexa), an atypical antipsychotic, is used off-label for managing nausea in advanced cancer patients but is linked to severe metabolic side effects, including hypertriglyceridemia. This case involves a metastatic gastric carcinoma patient with no known metabolic disorder who developed...
Shranjeno v:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2025-03-01
|
| Serija: | Current Problems in Cancer: Case Reports |
| Teme: | |
| Online dostop: | http://www.sciencedirect.com/science/article/pii/S2666621924000668 |
| Oznake: |
Brez oznak, prvi označite!
|